Dr. Elliot Michael Belenkov, MD

Dr. Belenkov practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.

Dr. Belenkov's NPI, 1093785396, was assigned on January 26, 2006. Dr. Belenkov graduated from Azerbaijan State Medical Institute in 1976. Dr. Belenkov holds New York license 162523.

Dr. Belenkov's primary practice is NYU Langone Perlmutter Cancer Center - 34th St, at 14 Wall St, New York, NY 10005 in New York County. The practice phone is (212) 263-1481.

Dr. Belenkov's primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dr. Belenkov is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Belenkov to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Belenkov practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Belenkov's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Belenkov is board certified in internal medicine by the American Board of Internal Medicine. Dr. Belenkov is licensed in New York.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Belenkov treats.

CMS data shows 3,736 Medicare services from Dr. Belenkov across 7 procedure codes in 2024, for 482 Medicare patients. Medicare paid $227,650 for them. Every service was in an office.

CMS counts 482 Medicare patients who saw Dr. Belenkov in 2024. The largest group is 75 to 84, with 190 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 76% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Belenkov's median patient age at 72, with 65% women.

In 2024, Dr. Belenkov wrote 530 Medicare Part D claims for 123 patients. 81% of them were for generic drugs. CMS names the drug for 355 of them, across 12 drugs with 11 or more claims each, at $24,331 in total drug cost. In 2023, CMS named 445 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Belenkov for performance year 2024, reported as part of a group. Dr. Belenkov accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 34 general payments to Dr. Belenkov from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Celgene Corporation paid the most, $1,125.

Dmand AI lists 8 awards for Dr. Belenkov, most recently America's Top Doctors in 2015.

Dr. Belenkov graduated from Azerbaijan State Medical Institute in 1976. Dr. Belenkov is a member of ASCO.

Dr. Belenkov is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.